Table 3. Posttreatment transcript levels (ΔCT) for subjects with MDD (N=22) and sex-, age-, race-matched ND controls (N=22).

Gene	MDD mean (s.d.)	CONTROL mean (s.d.)	P-value	q	Cohen's D
ADCY3	20.25 (1.85)	20.44 (1.96)	0.092	0.190	0.357
AMFR	19.33 (0.75)	19.33 (0.47)	0.913	0.913	0.004
ASAH1	15.98 (2.15)	16.04 (2.13)	0.680	0.716	0.065
ATP11C	18.78 (2.13)	18.48 (2.11)	0.123	0.208	0.363
CD59	20.09 (0.67)	19.79 (0.74)	0.125	0.208	0.355
CDR2	20.68 (1.23)	20.46 (0.66)	0.376	0.470	0.215
CMAS	22.55 (1.04)	23.04 (0.70)	0.076	0.190	0.481
DGKA	16.33 (0.72)	17.40 (0.89)	<0.001	0.005	0.883
FAM46A	18.84 (2.18)	19.04 (2.22)	0.232	0.331	0.309
IGSF4A/CADM1	21.50 (2.48)	22.19 (2.48)	0.001	0.005	0.862
KIAA1539	18.15 (0.62)	18.71 (0.50)	<0.001	0.005	0.840
MAF	21.16 (2.11)	21.10 (2.33)	0.555	0.653	0.026
MARCKS	16.22 (1.82)	16.64 (2.12)	0.010	0.040	0.558
NAGA	16.89 (2.15)	16.99 (2.14)	0.595	0.661	0.119
PSME1	17.04 (0.68)	17.46 (0.56)	0.033	0.094	0.533
PTP4A3	20.79 (0.74)	21.05 (0.64)	0.163	0.251	0.339
RAPH1	21.45 (1.07)	22.86 (0.60)	<0.001	0.005	1.086
SLC4A1	17.02 (1.16)	17.37 (0.80)	0.095	0.190	0.290
TLR7	18.52 (2.24)	18.92 (2.09)	0.016	0.533	0.550
ZNF291	22.48 (3.12)	21.95 (2.96)	0.373	0.470	0.249

Abbreviations: MDD, major depressive disorder; ND, nondepressed. Bold entries represent significant results.